Molecular Clue May Treat Autism Spectrum Disorder

Molecular Clue May Treat Autism Spectrum Disorder

Published: 2022-12-14
Author: Daegu Gyeongbuk Institute of Science and Technology (DGIST) | Contact:
Peer-Reviewed Publication: Yes | DOI:
Additional References: Autism Information Publications

Synopsis: Researchers identify the cell-specific molecular network of autism spectrum disorder, thereby laying the foundation for treating ASD. Most autism spectrum disorder patients have behavioral disorders, sometimes accompanied by other developmental disabilities. The multi-omics integrated analysis technology developed through this study has advanced the pathological understanding of autism spectrum disorder and made it possible to discover an integrated network ranging from molecular-level cell differentiation induced by a specific autism gene to biometric information.



Autism Spectrum Disorder (ASD)

Autism spectrum disorder (ASD) is a developmental disability caused by differences in the brain. Some people with ASD have a known difference, such as a genetic condition. Other causes are not yet known. People with ASD may behave, communicate, interact, and learn in ways that are different from most others. ASD begins before the age of 3 years and can last throughout a person’s life, although symptoms may improve over time. The abilities of people with ASD vary significantly.

Main Digest

Cntnap2-dependent molecular networks in autism spectrum disorder revealed through an integrative multi-omics analysis.

Professor Kim Min-sik’s team [...]

Read article at

Article Taxonomies

Categories: ,